PURPOSE: Our aim was to assess the effect of a moderate-intensity, year-long exercise program on the risk of colds and other upper respiratory tract infections in postmenopausal women. SUBJECTS: A total of 115 overweight and obese, sedentary, postmenopausal women in the Seattle area participated. METHODS: Participants were randomly assigned to the moderate-intensity exercise group or the control group. The intervention consisted of 45 minutes of moderate-intensity exercise 5 days per week for 12 months. Control participants attended once-weekly, 45-minute stretching sessions. Questionnaires asking about upper respiratory tract infections in the previous 3 months were administered quarterly during the course of the year-long trial. Poisson regression was used to estimate the effect of exercise on colds and other upper respiratory tract infections. RESULTS: Over 12 months, the risk of colds decreased in exercisers relative to stretchers (P = .02): In the final 3 months of the study, the risk of colds in stretchers was more than threefold that of exercisers (P = .03). Risk of upper respiratory tract infections overall did not differ (P = .16), yet may have been biased by differential proportions of influenza vaccinations in the intervention and control groups. CONCLUSIONS: This study suggests that 1 year of moderate-intensity exercise training can reduce the incidence of colds among postmenopausal women. These findings are of public health relevance and add a new facet to the growing literature on the health benefits of moderate exercise.
RCT Entities:
PURPOSE: Our aim was to assess the effect of a moderate-intensity, year-long exercise program on the risk of colds and other upper respiratory tract infections in postmenopausal women. SUBJECTS: A total of 115 overweight and obese, sedentary, postmenopausal women in the Seattle area participated. METHODS:Participants were randomly assigned to the moderate-intensity exercise group or the control group. The intervention consisted of 45 minutes of moderate-intensity exercise 5 days per week for 12 months. Control participants attended once-weekly, 45-minute stretching sessions. Questionnaires asking about upper respiratory tract infections in the previous 3 months were administered quarterly during the course of the year-long trial. Poisson regression was used to estimate the effect of exercise on colds and other upper respiratory tract infections. RESULTS: Over 12 months, the risk of colds decreased in exercisers relative to stretchers (P = .02): In the final 3 months of the study, the risk of colds in stretchers was more than threefold that of exercisers (P = .03). Risk of upper respiratory tract infections overall did not differ (P = .16), yet may have been biased by differential proportions of influenza vaccinations in the intervention and control groups. CONCLUSIONS: This study suggests that 1 year of moderate-intensity exercise training can reduce the incidence of colds among postmenopausal women. These findings are of public health relevance and add a new facet to the growing literature on the health benefits of moderate exercise.
Authors: Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe Journal: Ann Fam Med Date: 2012 Jul-Aug Impact factor: 5.166
Authors: Henry E Wang; John Baddley; Russell L Griffin; Suzanne Judd; George Howard; John P Donnelly; Monika M Safford Journal: Prev Med Date: 2014-04-24 Impact factor: 4.018
Authors: Connie J Rogers; David A Zaharoff; Kenneth W Hance; Susan N Perkins; Stephen D Hursting; Jeffrey Schlom; John W Greiner Journal: Vaccine Date: 2008-08-14 Impact factor: 3.641
Authors: Chidi N Obasi; Roger Brown; Tola Ewers; Shari Barlow; Michele Gassman; Aleksandra Zgierska; Christopher L Coe; Bruce Barrett Journal: Influenza Other Respir Viruses Date: 2012-11-21 Impact factor: 4.380
Authors: Aleksandra Zgierska; Chidi N Obasi; Roger Brown; Tola Ewers; Daniel Muller; Michele Gassman; Shari Barlow; Bruce Barrett Journal: Evid Based Complement Alternat Med Date: 2013-09-29 Impact factor: 2.629